RxDoctor Payments DataLook up a doctor →

Amanda Crosson

Gerontology · Englewood, FLNPI 1568024537

Payments from drug & device makers

$8,318in general payments, 2019–2025

Across 352 payments — averaging $23.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Incyte Corporation$634
  • Merck$548
  • Daiichi Sankyo Inc.$487
  • AstraZeneca$467
  • E.r. Squibb & Sons, L.L.C.$428
  • Lilly USA, LLC$421
  • plus $5K from 54 others

What the payments were for

  • Food & beverage$7,88695%
  • Education$4325%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Incyte Corporation21$634
Merck24$548
Daiichi Sankyo Inc.19$487
AstraZeneca(2 entities)20$467
E.r. Squibb & Sons, L.L.C.20$428
Lilly USA, LLC16$421
Bristol Myers Squibb17$388
Novartis19$344
Genentech USA, Inc.12$319
Seagen Inc.14$306
Gilead(2 entities)12$273
Johnson & Johnson(2 entities)13$263
Pfizer13$261
Bayer8$253
Astellas Pharma US Inc9$250
GSK8$239
Amgen8$145
AVEO Pharmaceuticals, Inc.4$136
Sumitomo Pharma America, Inc.7$133
Genmab U.S., Inc.1$122
Sobi, Inc6$117
Sanofi6$106
Myriad Genetic Laboratories, Inc.3$105
Jazz Pharmaceuticals Inc.3$83
Exelixis Inc.3$74
Springworks Therapeutics, Inc.2$72
AbbVie4$72
Boehringer Ingelheim3$69
Pharmaessentia USA Corporation2$65
Mirati Therapeutics, Inc.4$65
Eisai Inc.3$61
Takeda Pharmaceuticals U.S.A., Inc.3$58
Beigene USA, Inc.2$57
Pharmacyclics LLC, An Abbvie Company2$55
Stemline Therapeutics Inc.2$52
Array Biopharma Inc3$50
Beone Medicines USA, Inc.2$42
Janssen Scientific Affairs, LLC1$41
Puma Biotechnology, Inc.2$40
Dova Pharmaceuticals2$38
Servier Pharmaceuticals LLC2$38
Myovant Sciences Inc.2$38
Karyopharm Therapeutics Inc.2$33
Taiho Oncology, Inc.2$30
ADC Therapeutics America, Inc.1$27
Blueprint Medicines Corporation1$26
Recordati_rare_diseases_inc.1$24
Rigel Pharmaceuticals, Inc.1$24
Fennec Pharmaceuticals, Inc.1$23
Immunogen, Inc.1$23
Pharmacosmos Therapeutics Inc.1$23
Syndax Pharmaceuticals, Inc.1$22
Foundation Medicine, Inc.1$22
AMAG Pharmaceuticals, Inc.1$22
EMD Serono, Inc.1$21
Morphosys, US Inc.1$21
Coherus Oncology, Inc.1$21
CTI Biopharma Corp.1$21
EUSA Pharma (US) LLC1$20
Agios Pharmaceuticals, Inc.1$19

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$8,318 in reported general payments places this provider in the 95th percentile of 714 gerontology providers in Florida.

See all gerontology providers in Florida →

Medicare billing

Part B allowed, 2024
$5,494
Medicare patients
49
Services billed
544

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Anastrozole17$272
Letrozole11$233

Paid to pharmacies, not to this prescriber.

Other gerontology in Englewood

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →